Russia Announces mRNA Cancer Vaccine with Free Distribution Plan

Experts express skepticism over lack of clinical data as Russia prepares to release the vaccine in early 2025.

The Russian Ministry of Health has announced the development of an mRNA-based cancer vaccine, expected to be available in early 2025 and distributed free to patients in the country.
The vaccine claims to use personalized genetic information to help the immune system recognize and target cancer cells, a method currently being explored in global clinical trials.
Experts, including immunologists, have raised concerns about the lack of published clinical trial data and clarity on whether the vaccine targets specific cancers or has broader applications.
Russian scientists involved in the project credit advancements in artificial intelligence for accelerating the creation of personalized mRNA vaccines, potentially reducing development time to under an hour.
While the vaccine's pre-clinical trials reportedly showed promise in suppressing tumor growth, international scientists emphasize the need for peer-reviewed data to validate its efficacy and safety.